Literature DB >> 16008118

Validation of a colorimetric assay for the in vitro screening of inhibitors of angiotensin-converting enzyme (ACE) from plant extracts.

C P Serra1, S F Côrtes, J A Lombardi, A Braga de Oliveira, F C Braga.   

Abstract

A new method for the in vitro screening of plant extracts with potential angiotensin-converting enzyme (ACE) inhibitory activity is proposed. The method is based on the cleavage of the substrate hippuryl-glycyl-glycine by ACE and subsequent reaction with trinitrobenzenesulfonic acid to form 2,4,6-trinitrophenyl-glycyl-glycine, whose absorbance is determined at 415 nm in a microtitre plate reader. Rabbit lung dehydrated by acetone was employed as an enzyme source. Validation of the method showed satisfactory intra-day (CV = 7.63%) and inter-day precision (CV = 13.61%), recovery (97-102.1%), sensitivity (IC50 = 14.1 nmol/l) and linearity in the range 7.5-120 mmol/l of glycyl-glycine (r2 = 0.9921). Besides, the method showed good correlation with a HPLC assay already established for the screening of ACE inhibitors (r = 0.9935 and 0.9034, respectively, for captopril solutions and for plant extracts). The method involves only inexpensive reagents and apparatus.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16008118     DOI: 10.1016/j.phymed.2004.07.002

Source DB:  PubMed          Journal:  Phytomedicine        ISSN: 0944-7113            Impact factor:   5.340


  9 in total

1.  The Plethora of Angiotensin-Converting Enzyme-Processed Peptides in Mouse Plasma.

Authors:  Margarita Semis; Gabriel B Gugiu; Ellen A Bernstein; Kenneth E Bernstein; Markus Kalkum
Journal:  Anal Chem       Date:  2019-05-07       Impact factor: 6.986

2.  Chinese medicinal formula Fufang Xueshuantong capsule could inhibit the activity of angiotensin converting enzyme.

Authors:  Shujing Sheng; Yonggang Wang; Chaofeng Long; Weiwei Su; Xia Rong
Journal:  Biotechnol Biotechnol Equip       Date:  2014-07-18       Impact factor: 1.632

3.  Free Radicals Scavenging Capacity, Antidiabetic and Antihypertensive Activities of Flavonoid-Rich Fractions from Leaves of Trichilia emetica and Opilia amentacea in an Animal Model of Type 2 Diabetes Mellitus.

Authors:  Kiessoun Konaté; Kassi Yomalan; Oksana Sytar; Patrice Zerbo; Marian Brestic; Van Damme Patrick; Paul Gagniuc; Nicolas Barro
Journal:  Evid Based Complement Alternat Med       Date:  2014-01-28       Impact factor: 2.629

4.  Docking studies and biological activity of fosinopril analogs.

Authors:  Jayant Choudary; Suvarna G Kini; Sreedhara Ranganath Pai Karkala; Muhammad Mubeen
Journal:  Int J Med Chem       Date:  2014-07-06

Review 5.  Review of Angiotensin-converting Enzyme Inhibitory Assay: Rapid Method in Drug Discovery of Herbal Plants.

Authors:  Islamudin Ahmad; Arry Yanuar; Kamarza Mulia; Abdul Mun'im
Journal:  Pharmacogn Rev       Date:  2017 Jan-Jun

Review 6.  Bioactivities of the genus Combretum (Combretaceae): a review.

Authors:  Gedson Rodrigues de Morais Lima; Igor Rafael Praxedes de Sales; Marcelo Ricardo Dutra Caldas Filho; Neyres Zínia Taveira de Jesus; Heloina de Sousa Falcão; José Maria Barbosa-Filho; Analúcia Guedes Silveira Cabral; Augusto Lopes Souto; Josean Fechine Tavares; Leônia Maria Batista
Journal:  Molecules       Date:  2012-08-02       Impact factor: 4.411

7.  Encapsulated Mulberry Fruit Extract Alleviates Changes in an Animal Model of Menopause with Metabolic Syndrome.

Authors:  Jintanaporn Wattanathorn; Supannika Kawvised; Wipawee Thukham-Mee
Journal:  Oxid Med Cell Longev       Date:  2019-04-28       Impact factor: 6.543

Review 8.  Paving New Roads Towards Biodiversity-Based Drug Development in Brazil: Lessons from the Past and Future Perspectives.

Authors:  Fernão Castro Braga
Journal:  Rev Bras Farmacogn       Date:  2021-09-17       Impact factor: 2.010

9.  Antimetabolic Syndrome Effect of Phytosome Containing the Combined Extracts of Mulberry and Ginger in an Animal Model of Metabolic Syndrome.

Authors:  Nut Palachai; Jintanaporn Wattanathorn; Supaporn Muchimapura; Wipawee Thukham-Mee
Journal:  Oxid Med Cell Longev       Date:  2019-11-11       Impact factor: 6.543

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.